There is no Value in clinical trials - they are very expensive - Phase 2 and Phase 3 will cost at least $50 million and BRTX doesn't have access to Capital - then there is the cost of bringing the drug to market.
The percent of drugs that gain FDA approval is 10% or less.
Market Data 
Markets 
AI
